“卡氮芥肺”中的致命性气胸。
Fatal pneumothorax in "BCNU lung".
作者信息
Wilson K S, Brigden M L, Alexander S, Worth A
出版信息
Med Pediatr Oncol. 1982;10(2):195-9. doi: 10.1002/mpo.2950100215.
PMID:7070355
Abstract
A patient with recurrent glioma treated with BCNU developed pneumothorax and interstitial pulmonary fibrosis. She died from "BCNU lung" and its complications, although she was free of her initial disease.
摘要
一名接受卡氮芥治疗的复发性神经胶质瘤患者发生了气胸和间质性肺纤维化。尽管她最初的疾病已痊愈，但她死于“卡氮芥肺”及其并发症。
相似文献
1
Fatal pneumothorax in "BCNU lung".“卡氮芥肺”中的致命性气胸。
Med Pediatr Oncol. 1982;10(2):195-9. doi: 10.1002/mpo.2950100215.
2
Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.卡氮芥所致晚期肺损伤：卡氮芥对肺实质延迟效应的光镜与超微结构研究
J Pathol. 1991 May;164(1):31-6. doi: 10.1002/path.1711640106.
3
Failure of corticosteroids to prevent carmustine-induced pulmonary fibrosis in a woman with astrocytoma.皮质类固醇未能预防一名患有星形细胞瘤的女性发生卡莫司汀诱导的肺纤维化。
Arch Neurol. 1981 Jun;38(6):392-3. doi: 10.1001/archneur.1981.00510060094023.
4
Rapidly progressive, fatal pulmonary fibrosis induced by carmustine.卡莫司汀诱导的快速进展性致死性肺纤维化。
JAMA. 1980 Aug 15;244(7):687-8.
5
BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes.卡氮芥（1,3-双（2-氯乙基）-1-亚硝基脲）致肺。药物性肺改变。
Cancer. 1984 Aug 15;54(4):751-5. doi: 10.1002/1097-0142(1984)54:4<751::aid-cncr2820540427>3.0.co;2-u.
6
[Recurrent bilateral pneumothorax in progressive lung fibrosis following combination therapy with BCNU].[联合使用卡氮芥治疗进行性肺纤维化后复发性双侧气胸]
Prax Klin Pneumol. 1985 Mar;39(3):102-5.
7
Irreversible pulmonary toxicity after single course of BCNU.单次使用卡莫司汀后出现不可逆的肺部毒性。
Am J Med Sci. 1980 Jan-Feb;279(1):53-6. doi: 10.1097/00000441-198001000-00007.
8
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.1,3-双（2-氯乙基）-1-亚硝基脲（卡莫司汀）诱导的肺纤维化。
Neurosurgery. 1980 Dec;7(6):560-5. doi: 10.1227/00006123-198012000-00003.
9
Pulmonary toxicity from carmustine (BCNU): a case report.卡莫司汀（BCNU）引起的肺毒性：一例报告。
Med Pediatr Oncol. 1979;6(3):255-9. doi: 10.1002/mpo.2950060310.
10
Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
Mayo Clin Proc. 2003 May;78(5):630-4. doi: 10.4065/78.5.630.
引用本文的文献
1
Pneumothorax as an adverse drug event: an exploratory aggregate analysis of the US FDA AERS database including a confounding by indication analysis inspired by Cornfield's condition.气胸作为一种药物不良反应事件：美国 FDA AERS 数据库的探索性综合分析，包括基于 Cornfield 条件的混杂因素分析。
Int J Med Sci. 2013 Jun 13;10(8):965-73. doi: 10.7150/ijms.5377. Print 2013.
Zotero 插件